Plain-English translation of NCT05983757 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
The DUSK trial is testing whether a minimally invasive catheter procedure called endovascular thrombectomy—which removes blood clots from medium-sized brain blood vessels—works better than standard medical care alone for treating a specific type of stroke. People in this trial have had a stroke caused by a blood clot in smaller brain vessels, rather than the larger vessels typically treated with this procedure. Researchers want to see if this treatment can help more patients recover better within 90 days.
Most stroke thrombectomy studies have focused on larger blood vessel blockages, but many stroke patients have clots in medium-sized or smaller vessels where the benefit of this procedure is uncertain. This trial exists to determine whether removing these medium-vessel clots with a catheter helps patients recover better than medication alone.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will be randomly assigned to receive either the catheter procedure (endovascular thrombectomy) along with standard care, or standard medical care alone. The catheter procedure involves a thin tube guided through your blood vessels to the clot location in your brain to remove it; this is done as soon as possible after enrollment. All participants will have follow-up visits and brain imaging over 90 days, with a final assessment at 3 months to measure recovery and quality of life.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
United States